Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01634308

Enrollment

Unknown

Registered

2012-07-06

Start date

2010-06-30

Completion date

2012-06-30

Last updated

2012-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regeneration of Alveolar Tissue After Maxillary Sinus Floor Augmentation

Brief summary

The purpose of this Clinical study was to evaluate the Efficacy and Safety of bongros-BMP compared to Bio-oss for Regeneration of alveolar bone tissue after Maxillary sinus floor augmentation.

Interventions

DRUGNovosis(bongros/BMP-2)

DRUGBio-oss

Eligibility

Sex/Gender

ALL

Age

40 Years to 70 Years

Healthy volunteers

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026